bloodwork
LOINC parts

72,372 parts · page 1175 of 1,448 · all codes

PartNameTypeTests
LP443399-3 Fungal colony COMPONENT
LP443400-9 Observation^post transfusion reaction COMPONENT 2
LP443402-5 Specific gravity PROPERTY 23
LP443403-3 Color PROPERTY 35
LP443404-1 Entitic Mass/volume PROPERTY 4
LP443405-8 Entitic Moles/volume PROPERTY 1
LP443406-6 DistWidth PROPERTY 4
LP443407-4 Entitic mean volume PROPERTY 9
LP443408-2 RBC^BldCo SYSTEM 4
LP443409-0 Cord blood SUPER SYSTEM
LP443410-8 Erythrocyte/Specimen Volume COMPONENT 23
LP443411-6 Specimen Volume DIVISORS
LP443412-4 DDU METHOD 1
LP443413-2 FEU METHOD 1
LP443414-0 Calculated.4Ions METHOD 9
LP443415-7 Calculated.3Ions METHOD 2
LP443416-5 Isotopic based on 1.73 sq M METHOD 1
LP443417-3 Creatinine, Cystatin C and Urea-based formula (CKiD)/1.73 sq M METHOD 1
LP443418-1 Creatinine-based formula (MDRD)/1.73 sq M METHOD 3
LP443419-9 Cystatin C-based formula/1.73 sq M METHOD 1
LP443420-7 Creatinine-based formula (Schwartz)/1.73 sq M METHOD 1
LP443421-5 Creatinine-based formula (CKD-EPI)/1.73 sq M METHOD 1
LP443422-3 based on 1.73 sq M METHOD 1
LP443423-1 Creatinine and Cystatin C-based formula (CKD-EPI)/1.73 sq M METHOD 1
LP443424-9 Creatinine-based formula (CKD-EPI 2021)/1.73 sq M METHOD 1
LP443425-6 Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M METHOD 1
LP443426-4 Creatinine-based formula (MDRD)/1.73 sq M among black population METHOD 1
LP443427-2 Creatinine-based formula (CKD-EPI)/1.73 sq M among black population METHOD 1
LP443428-0 based on 1.73 sq M among black population METHOD 1
LP443429-8 Creatinine-based formula (MDRD)/1.73 sq M among female population METHOD 1
LP443430-6 Creatinine-based formula (MDRD)/1.73 sq M among male population METHOD 1
LP443431-4 Creatinine-based formula (MDRD)/1.73 sq M among non black population METHOD 1
LP443432-2 Creatinine-based formula (CKD-EPI)/1.73 sq M among non black population METHOD 1
LP443433-0 based on 1.73 sq M among non black population METHOD 1
LP443466-0 Source PROPERTY 2
LP443467-8 Specimen COMPONENT 2
LP443498-3 Botulinum neurotoxin producing species COMPONENT 1
LP443505-5 Endopep-MS METHOD 3
LP443506-3 cefTAZidime+cloxacillin COMPONENT 1
LP443518-8 Beta lactamase.AmpC type COMPONENT 1
LP443519-6 TGFBR3 and OGA gene rearrangements COMPONENT 1
LP443526-1 Alcoholic drink consumed COMPONENT 1
LP443530-3 Alcohol consumption environment COMPONENT 1
LP443531-1 Alcohol use pattern COMPONENT 1
LP443545-1 PANEL.SURVEY.WHYMPI CLASS
LP443547-7 WHYMPI METHOD 8
LP443548-5 Pre-Evaluation Questions COMPONENT 1
LP443552-7 Part 1 COMPONENT 1
LP443553-5 Part 2 COMPONENT 1
LP443554-3 Part 3 COMPONENT 1

← prev · next →